Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mona Fouad"'
Autor:
Omar Abdel-Rahman, Mona Fouad
Publikováno v:
Critical reviews in oncology/hematology. 94(2)
Background The randomized phase III trial of sunitinib versus interferon Alfa provided level-A evidence for the use of sunitinib in advanced clear cell renal cell carcinoma (RCC). This systematic literature review aims at the evaluation of the level
Autor:
Omar Abdel-Rahman, Mona Fouad
Publikováno v:
Critical reviews in oncology/hematology. 93(2)
We performed a systematic review and meta-analysis of the correlation between cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab.Eligible studies included phase I, II and III trials of patients with solid tumors o
Autor:
Mona Fouad, Omar Abdel-Rahman
Publikováno v:
Critical reviews in oncology/hematology. 92(3)
We performed a systematic review and comparative meta-analysis of cardiovascular toxicities associated with sunitinib, axitinib, cediranib or regorafenib; oral multi tyrosine kinase inhibitors.Eligible studies included randomized phase II and III tri
Autor:
Mona Fouad, Omar Abdel-Rahman
Publikováno v:
Critical reviews in oncology/hematology. 91(1)
Background Hepatocellular carcinoma is the fifth most common cancer worldwide and the third most common cause of cancer mortality. Advanced HCC is a distinct disease entity with limited approved treatment options and grave prognosis. So, we will expl